|
|
|
|
Protein engineering plays a transformative role in antibody drug development, enhancing stability, specificity, and functionality while paving the way for AI-driven design and personalized therapeutic strategies. Hear from protein engineering expert Thomas Cornell, as he details how this powerful capability can be leveraged to tailor therapies to meet the diverse needs of patients more precisely.
|
|
|
|
|
Learn how to harness the power of rapid analytical platform strategies and proven expertise, streamlining your drug development process while ensuring quality, consistency, and efficiency at every step. This reduces the time, resources, and risk in developing assays de novo.
|
|
|
|
|
Explore the vital role of drug formulation in transforming biologics into patient-friendly therapies, and uncover key insights into this critical step-by-step process from lab to clinical trials.
|
|
|
|
|
Process development bridges early discovery and clinical manufacturing, reducing risk, improving scalability, and aligning biologic programs with regulatory and commercial success from the start. Discover how a comprehensive approach that combines cutting-edge technologies, deep expertise, and collaborative partnerships can ensure that each product is developed with precision and efficiency, and meet the standards necessary for successful commercialization.
|
|
|
|
|
Strategic planning in early-phase development accelerates clinical progress, reduces risk, and lays the groundwork for scalable, compliant manufacturing and successful commercialization. Access this on-demand webinar to hear from MSAT experts on how to efficiently and effectively manufacture your biologic for clinical and commercial success.
|
|
|
|
|
|
|
Explore how enhanced cell line development platforms, like AbZelectPRO™, enable rapid DNA synthesis to research cell bank (RCB) timelines of just 10 weeks, achieving up to 10g/L in high-performing titers. Compare the benefits of random integration with semi-targeted (transposases) approaches for building cell lines.
|
|
|
|
|
|
|
Developability assessments are a key factor in a biologic's success, evaluating its manufacturability, safety, and efficacy. By proactively addressing concerns early on, we aim to enhance the likelihood of regulatory approval and downstream clinical success. Access our brochure to discover how this robust tool can empower you to make more informed, data-driven decisions about your biopharmaceutical.
|
|
|
|
|
Accelerated cell line development delivers high-titer biologics in weeks, supporting diverse modalities with robust analytics, scalable productivity, and proven stability across 60+ generations.
|
|
|
